China’s reaction to new U.S. tariffs will likely focus on domestic stimulus and strengthening ties with trading partners, analysts said.
Related Posts
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
Tesla shares tumble ahead of first-quarter earnings report
Tesla shares dropped almost 6% on Monday, a day before the company is scheduled to release first-quarter earnings.
Wall Street banks got meager payout from CoreWeave IPO
After waiting over three years for a billion-dollar-plus IPO from a U.S. tech company, Wall Street’s top banks only got a 2.8% fee.